The DOI matches its Crossref record; 35 of the 39 references it cites were found in a registry or an index, and 1 are not checked yet.
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Open accessAbstract
Background Data on patients with COVID-19 who have cancer are lacking. Here we characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify potential prognostic factors for mortality and severe illness.Methods In this cohort study, we collected de-identified data on patients with active or previous malignancy, aged 18 years and older, with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from the USA, Canada, and Spain from the COVID-19 and Cancer Consortium (CCC19) database for whom baseline data were added between March 17 and April 16, 2020. We collected data on baseline clinical conditions, medications, cancer diagnosis and treatment, and COVID-19 disease course. The primary endpoint was all-cause mortality within 30 days of diagnosis of COVID-19. We assessed the association between the outcome and potential prognostic variables using logistic regression analyses, partially adjusted for age, sex, smoking status, and obesity. This study is registered with ClinicalTrials.gov, NCT04354701, and is ongoing.Findings Of 1035 records entered into the CCC19 database during the study period, 928 patients met inclusion criteria for our analysis. Median age was 66 years (IQR 57-76), 279 (30%) were aged 75 years or older, and 468 (50%) patients were male. The most prevalent malignancies were breast (191 [21%]) and prostate (152 [16%]). 366 (39%) patients were on active anticancer treatment, and 396 (43%) had active (measurable) cancer. At analysis (May 7, 2020), 121 (13%) patients had died. In logistic regression analysis, independent factors associated with increased 30-day mortality, after partial adjustment, were: increased age (per 10 years; partially adjusted odds ratio 1·84, 95% CI 1·53-2·21), male sex (1·63, 1·07-2·48), smoking status (former smoker vs never smoked: 1·60, 1·03-2·47), number of comorbidities (two vs none: 4·50, 1·33-15·28), Eastern Cooperative Oncology Group performance status of 2 or higher (status of 2 vs 0 or 1: 3·89, 2·11-7·18), active cancer (progressing vs remission: 5·20, 2·77-9·77), and receipt of azithromycin plus hydroxychloroquine (vs treatment with neither: 2·93, 1·79-4·79; confounding by indication cannot be excluded). Compared with residence in the US-Northeast, residence in Canada (0·24, 0·07-0·84) or the US-Midwest (0·50, 0·28-0·90) were associated with decreased 30-day all-cause mortality. Race and ethnicity, obesity status, cancer type, type of anticancer therapy, and recent surgery were not associated with mortality.Interpretation Among patients with cancer and COVID-19, 30-day all-cause mortality was high and associated with general risk factors and risk factors unique to patients with cancer. Longer follow-up is needed to better understand the effect of COVID-19 on outcomes in patients with cancer, including the ability to continue specific cancer treatments.Funding American Cancer Society, National Institutes of Health, and Hope Foundation for Cancer Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This is particularly true of older adults with cancer, who may be among the most vulnerable to the effects of COVID-19 due to their immunocompromised status and increased presence of comorbidities [1,2,3,4,5].”
From The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review (2022) · cites this paper as [1]
In the citing paper
“Age and cancer diagnosis are significant predictors of adverse outcomes of the COVID-19 infection.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Esteves-Vieira, V., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedHarris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
Research works printed but not linked: 1
- Smith, 2020, Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2, bioRxiv
Cited by
Sorted by citations
Items 201–300 of 1,002
Meir, J., Abid, M. A., & Abid, M. B. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.09.016 · Cited by 51
Cancer Patients and Risk of Mortality for COVID-19
Curigliano, G. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.006 · Cited by 49
Epigenetic mechanisms influencing COVID-19
Sen, R., Garbati, M. R., Bryant, K. F., & Lu, Y. (2021) · Genome · doi:10.1139/gen-2020-0135 · Cited by 49
Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients
Sun, L., Surya, S. L., Le, A. N., Desai, H., Doucette, A. G., Gabriel, P. E., Ritchie, M. D., Rader, D. J., Maillard, I. P., Bange, E. M., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa120 · Cited by 49
Self-citationTerpos, E., Musto, P., Engelhardt, M. M., Delforge, M., Cook, G., Gay, F., van de Donk, N. W. C. J., Ntanasis‐Stathopoulos, I., Vangsted, A. J., Driessen, C., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01920-1 · Cited by 49
Raeisi, T., Mozaffari, H., Sepehri, N., Darand, M., Razi, B., Garousi, N., Alizadeh, M., & Alizadeh, S. (2020) · Eating and Weight Disorders · doi:10.1007/s40519-021-01269-3 · Cited by 45
Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation
Basu, P. S., Alhomoud, S. J., Taghavi, K., Carvalho, A. L., Lucas, E., & Baussano, I. (2021) · JCO Global Oncology · doi:10.1200/go.21.00033 · Cited by 48
Borah, P., Mirgh, S. P., Sharma, S. K., Bansal, S. K., Dixit, A., Dolai, T. K., Lunkad, S., Gupta, N. K., Singh, G., Jain, A., et al. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102525 · Cited by 47
Comparison of Cancer Patients to Non-Cancer Patients among COVID-19 Inpatients at a National Level
Bernard, A., Cottenet, J., Bonniaud, P., Piroth, L., Arveux, P., Tubert‐Bitter, P., & Quantin, C. (2021) · Cancers · doi:10.3390/cancers13061436 · Cited by 47
Zomerdijk, N., Jongenelis, M. I., Short, C. E., Smith, A., Turner, J., & Huntley, K. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06369-5 · Cited by 49
Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment
Grinshpun, A., Rottenberg, Y., Ben-Dov, I., Djian, E., Wolf, D. G., & Kadouri, L. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100283 · Cited by 48
Rolfo, C., Meshulami, N., Russo, A., Krammer, F., García‐Sastre, A., Mack, P. C., Gomez, J. E., Bhardwaj, N., Benyounes, A., Sirera, R., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.11.001 · Cited by 50
Self-citationImpact of COVID-19 in patients with multiple myeloma based on a global data network
Martínez‐López, J., Hernández, G., Alonso, R., Sánchez‐Pina, J. M., Zamanillo, I., López‐Muñoz, N., Íñiguez, R., Cuéllar, C., Calbacho, M., Paciello, M. L., et al. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00588-z · Cited by 47
Azithromycin through the Lens of the COVID-19 Treatment
Kournoutou, G. G., & Dinos, G. P. (2022) · Antibiotics · doi:10.3390/antibiotics11081063 · Cited by 50
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
Grever, M. R., Andritsos, L. A., Banerji, V., Barrientos, J. C., Bhat, S. A., Blachly, J. S., Call, T. G., Cross, M., Dearden, C. E., Demeter, J., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01257-7 · Cited by 48
COVID-19 in patients with cancer: managing a pandemic within a pandemic
Horn, L., & Garassino, M. C. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00441-5 · Cited by 46
Gudiol, C., Durà-Miralles, X., Hernández-Jiménez, P., Martínez-Cutillas, M., Fernández‐Avilés, F., Machado, M., Vázquez, L., Martín‐Dávila, P., Castro, N. D., Abdala, E., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.07.014 · Cited by 46
Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer
Figueiredo, J. C., Merin, N. M., Hamid, O., Choi, S. Y., Lemos, T., Cozen, W., Nguyen, N., Finster, L. J., Foley, J., Darrah, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-3554 · Cited by 46
Oncology patients’ perceptions of and experiences with COVID-19
Miaskowski, C. A., Paul, S. M., Snowberg, K. E., Abbott, M., Borno, H. T., Chang, S. M., Chen, L. M., Cohen, B., Cooper, B. A., Hammer, M. J., et al. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05684-7 · Cited by 45
An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients
Nair, V. V., Jandovitz, N., Hirsch, J. S., Abate, M. T., Satapathy, S. K., Roth, N. C., Miyara, S. J., Guevara, S., Kressel, A. M., Xiang, A., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16460 · Cited by 47
Self-citationThe Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review
Majeed, A., Wright, T., Guo, B., Arora, R. S., Lam, C. G., & Martiniuk, A. L. C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.869752 · Cited by 48
Langerbeins, P., & Eichhorst, B. F. (2021) · Acta Haematologica · doi:10.1159/000514071 · Cited by 45
Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment
Canonico, M. E., Santoro, C., Avvedimento, M., Giugliano, G., Mandoli, G. E., Prastaro, M., Franzone, A., Piccolo, R., Ilardi, F., Cameli, M., et al. (2022) · Biomolecules · doi:10.3390/biom12020259 · Cited by 45
Cancer therapy and treatments during COVID-19 era
Akula, S. M., Abrams, S. L., Steelman, L. S., Candido, S., Libra, M., Lerpiriyapong, K., Cocco, L., Ramazzotti, G., Ratti, S., Follo, M. Y., et al. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100739 · Cited by 47
Giesen, N., Sprute, R., Rüthrich, M. M., Khodamoradi, Y., Mellinghoff, S. C., Beutel, G., Lueck, C., Koldehoff, M., Hentrich, M., Sandherr, M., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.033 · Cited by 48
Shahidsales, S., Aledavood, S. A., Joudi, M., Molaie, F., Esmaily, H., & Javadinia, S. A. (2021) · Cancer Reports · doi:10.1002/cnr2.1378 · Cited by 43
Impact of COVID-19 on Pediatric Immunocompromised Patients
Connelly, J. A., Chong, H., Esbenshade, A. J., Frame, D. G., Failing, C., Secord, E. A., & Walkovich, K. J. (2021) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2021.05.007 · Cited by 45
One‐year mortality and consequences of COVID ‐19 in cancer patients: A cohort study
Chai, C., Feng, X., Lü, M., Li, S., Chen, K., Wang, H., Wang, W., Tang, Z., Cheng, G., Wu, X., et al. (2021) · IUBMB Life · doi:10.1002/iub.2536 · Cited by 42
Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study
Au, L., Boos, L. A., Swerdlow, A. J., Byrne, F., Shepherd, S. T. C., Fendler, A., & Turajlic, S. (2020) · Cell · doi:10.1016/j.cell.2020.09.005 · Cited by 43
Park, R., Lee, S. A., Kim, S. Y., de Melo, A. C., & Kasi, A. (2020) · Acta Oncologica · doi:10.1080/0284186x.2020.1837946 · Cited by 43
Self-citationClinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities
Wang, L., Sun, Y., Yuan, Y., Mei, Q., & Yuan, X. (2020) · Aging · doi:10.18632/aging.104205 · Cited by 43
Chen, X., Wang, L., Liu, L., Jiang, M., Wang, W., Zhou, X., & Shao, J. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-05994-4 · Cited by 43
Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
Bilich, T., Roerden, M., Maringer, Y., Nelde, A., Heitmann, J. S., Dubbelaar, M. L., Peter, A., Hörber, S., Bauer, J., Rieth, J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0191 · Cited by 41
Shmueli, E., Itay, A., Margalit, O., Berger, R., Halperin, S., Jurkowicz, M., Levin, E. G., Levy, I., Olmer, L., Regev-Yochay, G., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.08.007 · Cited by 46
Webber, T. B., Provinciali, N., Musso, M., Ugolini, M., Boitano, M., Clavarezza, M., D’Amico, M., Defferrari, C., Gozza, A., Briata, I. M., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.09.030 · Cited by 43
Villalobos, N. V. F., Ott, J. J., Klett-Tammen, C. J., Bockey, A. J., Vanella, P., Krause, G., & Lange, B. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01732-3 · Cited by 43
Cancer and COVID-19: what do we really know?
Poortmans, P. M., Guarneri, V., & Cardoso, M. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31240-x · Cited by 42
Ramaswamy, A., Nayak, L., Moulik, N. R., Sengar, M., Chinnaswamy, G., Jobanputra, K. N., Shah, M. J., Kapoor, A., Joshi, A., Kumar, A., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3423 · Cited by 42
Self-citationBiernat, M., Zińczuk, A., Biernat, P., Bogucka‐Fedorczuk, A., Kwiatkowski, J., Kalicińska, E., Marciniak, D. M., Simon, K. A., & Wróbel, T. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104574 · Cited by 42
Yang, L., Lu, H., Wang, W., Liu, Q., & Zhu, C. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1837628 · Cited by 42
Immunotherapy use outside clinical trial populations: never say never?
Rzeniewicz, K., Larkin, J., Menzies, A. M., & Turajlic, S. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.03.199 · Cited by 42
Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
Tremblay, D. A., Seah, C., Schneider, T., Bhalla, S., Feld, J., Naymagon, L., Wang, B., Patel, V. G., Jun, T. W., Jandl, T. A., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3457 · Cited by 40
Mollalo, A., Rivera, K. M., & Vahabi, N. (2021) · Sustainable Cities and Society · doi:10.1016/j.scs.2021.102738 · Cited by 42
Agbarya, A., Sarel, I., Ziv‐Baran, T., Agranat, S., Schwartz, O., Shai, A., Nordheimer, S., Fenig, S., Shechtman, Y., Kozlener, E., et al. (2021) · Cancers · doi:10.3390/cancers13164191 · Cited by 43
Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body
Kopańska, M., Barnaś, E., Błajda, J., Kuduk, B., Łagowska, A., & Banaś-Ząbczyk, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084178 · Cited by 45
The impact of COVID-19 on systemic anticancer treatment delivery in Scotland
Baxter, M. A., Murphy, J. M., Cameron, D., Jordan, J., Crearie, C., Lilley, C., Sadozye, A., Maclean, M., Hall, P. S., Phillips, A., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01262-8 · Cited by 41
Gobiņa, I., Avotiņš, A., Kojalo, U., Strēle, I., Pildava, S., Villeruša, A., & Briģis, Ģ. (2022) · BMC Public Health · doi:10.1186/s12889-022-13491-4 · Cited by 34
Agrati, C., Bartolini, B., Bordoni, V., Locatelli, F., Capobianchi, M. R., Di, A., Castilletti, C., & Ippolito, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147871 · Cited by 48
Bytyci, J., Ying, Y., & Lee, L. Y. W. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1259 · Cited by 44
Yuan, M., Zhu, Y. J., Ren, Y., Chen, L., Dai, X., Wang, Y., Huang, Y., & Wang, H. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04142 · Cited by 40
Francescangeli, F., Angelis, M. L. D., Baiocchi, M., Rossi, R., Biffoni, M., & Zeuner, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.592891 · Cited by 41
Morais, S., Antunes, L., Rodrigues, J. R., Fontes, F., Bento, M. J., & Lunet, N. (2021) · International Journal of Cancer · doi:10.1002/ijc.33532 · Cited by 43
Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic
Park, K. U., Gregory, M. E., Bazan, J. G., Lustberg, M. B., Rosenberg, S. M., Blinder, V. S., Sharma, P., Pusztai, L., Shen, C., Partridge, A. H., et al. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06153-3 · Cited by 40
Self-citationNadkarni, A. R., Vijayakumaran, S. C., Gupta, S., & Divatia, J. V. (2021) · JCO Global Oncology · doi:10.1200/go.21.00072 · Cited by 41
Self-citationSARS-CoV-2 Vaccine Development: An Overview and Perspectives
Liu, Y., Wang, K., Massoud, T. F., & Paulmurugan, R. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00109 · Cited by 40
National Health Systems and COVID-19 Death Toll Doubling Time
Alfaro, M. D., Muñoz-Godoy, D., Vargas, M., Fuertes, G., Durán, C., Ternero, R., Sabattin, J., Gutierrez, S., & Karstegl, N. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.669038 · Cited by 39
Linardou, H., Spanakis, N., Koliou, G.-A., Christopoulou, A. N., Karageorgopoulou, S., Alevra, N., Vagionas, A., Tsoukalas, N., Sgourou, S., Fountzilas, E., et al. (2021) · Cancers · doi:10.3390/cancers13184621 · Cited by 38
Pieren, D. K. J., Kuguel, S. G., Rosado, J., Robles, A. G., Rey-Cano, J., Mancebo-Pérez, C., Esperalba, J., Falcó, V., Buzón, M. J., & Genescà, M. (2023) · Nature Communications · doi:10.1038/s41467-023-37559-w · Cited by 38
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
Belluomini, L., Caldart, A., Avancini, A., Dodi, A., Trestini, I., Kadrija, D., Sposito, M., Tregnago, D., Casali, M., Riva, S. T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010042 · Cited by 40
Giesen, N., Sprute, R., Rüthrich, M. M., Khodamoradi, Y., Mellinghoff, S. C., Beutel, G., Lueck, C., Koldehoff, M., Hentrich, M., Sandherr, M., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.009 · Cited by 38
Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic
Frey, M. K., Chapman‐Davis, E., Glynn, S. M., Lin, J. J., Ellis, A. E., Tomita, S., Fowlkes, R. K., Thomas, C., Christos, P. J., Cantillo, E., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.11.017 · Cited by 43
Lung cancer patients with COVID-19 in Spain: GRAVID study
Provencio, M., Gallego, J. M. M., Calles, A., Antoñanzas, M., Pangua, C., Mielgo-Rubio, X., Nadal, E., Castro, R. L., Martín, A. L., del Barco, E., et al. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.05.014 · Cited by 38
Schmidt, A. L., Tucker, M. D., Bakouny, Z., Labaki, C., Hsu, C., Shyr, Y., Armstrong, A. J., Beer, T. M., Bijjula, R. R., Bilen, M. A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.34330 · Cited by 38
Self-citationSchulz, E., Hodl, I., Forstner, P., Hatzl, S., Sareban, N., Moritz, M., Fessler, J., Dreo, B., Uhl, B., Url, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803742 · Cited by 41
Choueiri, T. K., Labaki, C., Bakouny, Z., Hsu, C., Schmidt, A. L., Lopes, G. D. L., Jr., Hwang, C., Singh, S. R. K., Jani, C., Weissmann, L. B., et al. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100445 · Cited by 39
Self-citationde Lusignan, S., Joy, M., Oke, J. L., McGagh, D., Nicholson, B. D., Sheppard, J. P., Akinyemi, O., Amirthalingam, G., Brown, K. E., Byford, R. C., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.08.037 · Cited by 37
Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward
Gupta, K., Gandhi, S., Mebane, A., Singh, A., Vishnuvardhan, N., & Patel, E. U. (2020) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2020.100285 · Cited by 38
Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center
Fernandes, G. A., Feriani, D., Silva, I. L. A. F. E., Silva, D. R. M. E., Arantes, P. E., Canteras, J. D. S., da Silva, R. R., & Curado, M. P. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.01.003 · Cited by 37
Hlubocky, F. J., Back, A. L., Shanafelt, T. D., Gallagher, C. M., Burke, J. M., Kamal, A. H., Paice, J. A., Page, R. D., Spence, R., McGinnis, M. M., et al. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00147 · Cited by 36
Self-citationLearning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Elkrief, A., Wu, J. T.-Y., Jani, C., Enriquez, K. T., Glover, M. J., Shah, M. R., Shaikh, H. G., Beeghly-Fadiel, A. C., French, B. C., Jhawar, S. R., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1368 · Cited by 36
Self-citationFu, C., Stoeckle, J. H., Masri, L. S., Pandey, A., Cao, M., Littman, D., Rybstein, M. D., Saith, S. E., Yarta, K., Rohatgi, A., et al. (2021) · Cancer · doi:10.1002/cncr.33657 · Cited by 36
Naranbhai, V., Denis, K. S., Lam, E. C., Ofoman, O., García-Beltrán, W. F., Berrios, C., Bhan, A. K., Gainor, J. F., Balazs, A. B., Iafrate, A. J., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2021.12.002 · Cited by 34
Self-citationLenihan, D. J., Carver, J. R., Porter, C., Liu, J. E., Dent, S. F., Thavendiranathan, P., Mitchell, J. D., Nohria, A., Fradley, M. G., Pusic, I., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21635 · Cited by 36
Self-citationReaddressing the Needs of Cancer Survivors During COVID-19: A Path Forward
Jones, J. M., Saeed, H., Katz, M. S., Lustberg, M. B., Forster, V. J., & Nekhlyudov, L. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa200 · Cited by 35
Self-citationCOVID-19 mortality in cancer patients: a report from a tertiary cancer centre in India
Mehta, A., Vasudevan, S., Parkash, A., Sharma, A., Vashist, T., & Krishna, V. (2021) · PeerJ · doi:10.7717/peerj.10599 · Cited by 36
Choi, J. Y., Park, I. J., Lee, H. G., Cho, E., Kim, Y. I., Kim, C. W., Yoon, Y. S., Lim, S., Yu, C. S., & Kim, J. C. (2021) · Cancers · doi:10.3390/cancers13092221 · Cited by 36
Challenges posed by COVID‐19 in cancer patients: A narrative review
Afshar, Z. M., Hosseinzadeh, R., Barary, M., Ebrahimpour, S., Alijanpour, A., Sayad, B., Hosseinzadeh, D., Miri, S. R., Sio, T. T. W., Sullman, M. J. M., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4519 · Cited by 36
Sakuraba, A., Luna, A., & Micić, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01233-3 · Cited by 36
Pritchett, J. C., Borah, B. J., Desai, A. P., Xie, Z., Saliba, A. N., Leventakos, K., Coffey, J. D., Pearson, K. K., Speicher, L. L., Orenstein, R., et al. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00307 · Cited by 32
Self-citationNakamura, S., Kanemasa, Y., Atsuta, Y., Fujiwara, S., Tanaka, M., Fukushima, K., Kobayashi, T., Shimoyama, T., Omuro, Y., Sekiya, N., et al. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01837-0 · Cited by 36
Mair, M. J., Berger, J. M., Mitterer, M., Gansterer, M., Bathke, A. C., Trutschnig, W., Berghoff, A. S., Perkmann, T., Haslacher, H., Lamm, W. W., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.01.019 · Cited by 34
Conod, A., Silvano, M., & Altaba, A. R. I. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110490 · Cited by 34
El‐Sharkawi, D., & Iyengar, S. (2020) · British Journal of Haematology · doi:10.1111/bjh.16956 · Cited by 37
Immunometabolic Status of COVID-19 Cancer Patients
Sica, A., Colombo, M. P., Trama, A., Horn, L., Garassino, M. C., & Torri, V. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2020 · Cited by 35
Leso, V., Fontana, L., & Iavicoli, I. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031030 · Cited by 35
Mahboub, B. H., Bataineh, M. T. A., Alshraideh, H. A., Hamoudi, R., Salameh, L. I. J., & Shamayleh, A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.592336 · Cited by 35
Roel, E., Pistillo, A., Recalde, M., Fernández-Bertolín, S., Aragón, M., Soerjomataram, I., Jenab, M., Puente, D., Prieto-Alhambra, D., Burn, E., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33846 · Cited by 17
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review
Bonuomo, V., Ferrarini, I., Dell’Eva, M., Sbisà, E., Krampera, M., & Visco, C. (2021) · World Journal of Virology · doi:10.5501/wjv.v10.i6.312 · Cited by 35
COVID-19 Pandemic: Impact on Cancer Patients
Rucińska, M., & Nawrocki, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912470 · Cited by 39
Simons, D., Shahab, L., Brown, J., & Perski, O. (2020) · doi:10.32388/ujr2aw.8 · Cited by 34
Koinig, K. A., Arnold, C., Lehmann, J., Giesinger, J., Köck, S., Willenbacher, W., Weger, R., Holzner, B., Ganswindt, U., Wolf, D., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3950 · Cited by 34
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid
Calles, A., Aparicio, I., Alva, M., Beranek, M. B., Gutiérrez, N., Soto, J. A., Arregui, M., Tirado, V. C., Álvarez, E. L., del Monte-Millán, M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01777 · Cited by 35
Aldea, M. D., Michot, J., Danlos, F., Ribas, A., & Soria, J. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0144 · Cited by 33
The Impact of COVID-19 on Patients With Cancer
Rodriguez, G. M., Ferguson, J. M., Kurian, A. W., Bondy, M. L., & Patel, M. I. (2021) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000865 · Cited by 36
Lama, Y., Davidoff, A. J., Vanderpool, R. C., & Jensen, R. E. (2021) · Journal of Medical Internet Research · doi:10.2196/34616 · Cited by 34
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
Heitmann, J. S., Tandler, C., Marconato, M., Nelde, A., Habibzada, T., Rittig, S. M., Tegeler, C. M., Maringer, Y., Jaeger, S. U., Denk, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40758-0 · Cited by 37
Park, R., Chidharla, A., Mehta, K. D., Sun, W., Wulff-Burchfield, E. M., & Kasi, A. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100519 · Cited by 33
Self-citationChanges in Lung Cancer Treatment as a Result of the Coronavirus Disease 2019 Pandemic
Elkrief, A., Kazandjian, S., & Bouganim, N. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.4408 · Cited by 33
Self-citationSorouri, M., Kasaeian, A., Mojtabavi, H., Radmard, A. R., Kolahdoozan, S., Anushiravani, A., Khosravi, B., Pourabbas, S. M., Eslahi, M., Sirusbakht, A., et al. (2020) · Infectious Agents and Cancer · doi:10.1186/s13027-020-00339-y · Cited by 33
Mandalà, M., Lorigan, P. C., Luca, M. D., Bianchetti, A., Merelli, B., Bettini, A., Bonomi, L., Nahm, S. H., Vitale, M. G., Negrini, G., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001694 · Cited by 33
Metadata
- Authors
- Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., Grivas, P., Painter, C. A., Peters, S., Thompson, M. A., Bakouny, Z., Batist, G., Bekaii-Saab, T., Bilen, M. A., Bouganim, N., Larroya, M. B., Castellano, D., Del Prete, S. A., Doroshow, D. B., Egan, P. C., Elkrief, A., Farmakiotis, D., Flora, D., Galsky, M. D., Glover, M. J., Griffiths, E. A., Gulati, A. P., Gupta, S., Hafez, N., Halfdanarson, T. R., Hawley, J. E., Hsu, E., Kasi, A., Khaki, A. R., Lemmon, C. A., Lewis, C., Logan, B., Masters, T., McKay, R. R., Mesa, R. A., Morgans, A. K., Mulcahy, M. F., Panagiotou, O. A., Peddi, P., Pennell, N. A., Reynolds, K., Rosen, L. R., Rosovsky, R., Salazar, M., Schmidt, A., Shah, S. A., Shaya, J. A., Steinharter, J., Stockerl-Goldstein, K. E., Subbiah, S., Vinh, D. C., Wehbe, F. H., Weissmann, L. B., Wu, J. T.-Y., Wulff-Burchfield, E., Xie, Z., Yeh, A., Yu, P. P., Zhou, A. Y., Zubiri, L., Mishra, S., Lyman, G. H., Rini, B. I., Warner, J. L., Abidi, M., Acoba, J. D., Agarwal, N., Ahmad, S., Ajmera, A., Altman, J., Angevine, A. H., Azad, N., Bar, M. H., Bardia, A., Barnholtz-Sloan, J., Barrow, B., Bashir, B., Belenkaya, R., Berg, S., Bernicker, E. H., Bestvina, C., Bishnoi, R., Boland, G., Bonnen, M., Bouchard, G., Bowles, D. W., Busser, F., Cabal, A., Caimi, P., Carducci, T., Casulo, C., Chen, J. L., Clement, J. M., Chism, D., Cook, E., Curran, C., Daher, A., Dailey, M., Dahiya, S., Deeken, J., Demetri, G. D., DiLullo, S., Duma, N., Elias, R., Faller, B., Fecher, L. A., Feldman, L. E., Friese, C. R., Fu, P., Fu, J., Futreal, A., Gainor, J., Garcia, J., Gill, D. M., Gillaspie, E. A., Giordano, A., Glace, (. G., Grothey, A., Gulati, S., Gurley, M., Halmos, B., Herbst, R., Hershman, D., Hoskins, K., Jain, R. K., Jabbour, S., Jha, A., Johnson, D. B., Joshi, M., Kelleher, K., Kharofa, J., Khan, H., Knoble, J., Koshkin, V. S., Kulkarni, A. A., Lammers, P. E., Leighton, J. C., Lewis, M. A., Li, X., Li, A., Lo, K. M. S., Loaiza-Bonilla, A., LoRusso, P., Low, C. A., Lustberg, M. B., Mahadevan, D., Mansoor, A.-H., Marcum, M., Markham, M. J., Handy Marshall, C., Mashru, S. H., Matar, S., McNair, C., McWeeney, S., Mehnert, J. M., Menendez, A., Menon, H., Messmer, M., Monahan, R., Mushtaq, S., Nagaraj, G., Nagle, S., Naidoo, J., Nakayama, J. M., Narayan, V., Nelson, H. H., Nemecek, E. R., Nguyen, R., Nuzzo, P. V., Oberstein, P. E., Olszewski, A. J., Owenby, S., Pasquinelli, M. M., Philip, J., Prabhakaran, S., Puc, M., Ramirez, A., Rathmann, J., Revankar, S. G., Rho, Y. S., Rhodes, T. D., Rice, R. L., Riely, G. J., Riess, J., Rink, C., Robilotti, E. V., Rosenstein, L., Routy, B., Rovito, M. A., Saif, M. W., Sanyal, A., Schapira, L., Schwartz, C., Serrano, O., Shah, M., Shah, C., Shaw, G., Shergill, A., Shouse, G., Soares, H. P., Solorzano, C. C., Srivastava, P. K., Stauffer, K., Stover, D. G., Stratton, J., Stratton, C., Subbiah, V., Tamimi, R., Tannir, N. M., Topaloglu, U., Van Allen, E., Van Loon, S., Vega-Luna, K., Venepalli, N., Verma, A. K., Vikas, P., Wall, S., Weinstein, P. L., Weiss, M., Wise-Draper, T., Wood, W. A., Xu, W. (., Yackzan, S., Zacks, R., Zhang, T., Zimmer, A. J., & West, J.
- Affiliations
- Dana-Farber Cancer Institute (US)
- The University of Texas at San Antonio Health Science Center (US)
- Vanderbilt-Ingram Cancer Center (US)
- National Cancer Institute (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Connecticut (US)
- University of Washington (US)
- University of Lausanne (CH)
- Aurora Health Care (US)
- Jewish General Hospital (CA)
- Winship Cancer Institute (US)
- McGill University Health Centre (CA)
- Hospital Universitario 12 De Octubre (ES)
- Tisch Cancer Institute (US)
- Brown University (US)
- St. Elizabeth Healthcare (US)
- Stanford University (US)
- Roswell Park Comprehensive Cancer Center (US)
- Stamford Hospital (US)
- Cleveland Clinic (US)
- Yale University (US)
- Mayo Clinic (US)
- Herbert Irving Comprehensive Cancer Center (US)
- Hartford Hospital (US)
- University of Kansas Medical Center (US)
- University of California San Diego (US)
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University (US)
- Willis-Knighton Cancer Center (US)
- Harvard University (US)
- Washington University in St. Louis (US)
- Louisiana State University Health Sciences Center New Orleans (US)
- Mount Auburn Hospital (US)
- Corresponding author
- Warner, Jeremy L
- ORCID
- Kuderer, Nicole M
- Choueiri, Toni K
- Shah, Dimpy P
- Shyr, Yu
- Rubinstein, Samuel M
- Rivera, Donna R
- Shete, Sanjay
- Hsu, Chih-Yuan
- Desai, Aakash
- Grivas, Petros
- Painter, Corrie A
- Peters, Solange
- Thompson, Michael A
- Bakouny, Ziad
- Batist, Gerald
- Bilen, Mehmet A
- Bouganim, Nathaniel
- Larroya, Mateo Bover
- Castellano, Daniel
- Doroshow, Deborah B
- Egan, Pamela C
- Elkrief, Arielle
- Farmakiotis, Dimitrios
- Flora, Daniel
- Galsky, Matthew D
- Glover, Michael J
- Griffiths, Elizabeth A
- Gupta, Shilpa
- Hafez, Navid
- Halfdanarson, Thorvardur R
- Hawley, Jessica E
- Hsu, Emily
- Kasi, Anup
- Khaki, Ali R
- Lemmon, Christopher A
- McKay, Rana R
- Mesa, Ruben A
- Morgans, Alicia K
- Mulcahy, Mary F
- Panagiotou, Orestis A
- Peddi, Prakash
- Pennell, Nathan A
- Reynolds, Kerry
- Rosovsky, Rachel
- Schmidt, Andrew
- Shah, Sumit A
- Shaya, Justin A
- Stockerl-Goldstein, Keith E
- Subbiah, Suki
- Vinh, Donald C
- Wehbe, Firas H
- Wu, Julie Tsu-Yu
- Wulff-Burchfield, Elizabeth
- Xie, Zhuoer
- Yeh, Albert
- Yu, Peter P
- Zhou, Alice Y
- Zubiri, Leyre
- Mishra, Sanjay
- Lyman, Gary H
- Rini, Brian I
- Warner, Jeremy L
- Abidi, Maheen
- Acoba, Jared D.
- Agarwal, Neeraj
- Ahmad, Syed
- Ajmera, Archana
- Altman, Jessica
- Bardia, Aditya
- Bashir, Babar
- Belenkaya, Rimma
- Berg, Stephanie
- Bernicker, Eric H.
- Bestvina, Christine
- Bishnoi, Rohit
- Boland, Genevieve
- Bonnen, Mark
- Bowles, Daniel W.
- Cabal, Angelo
- Caimi, Paolo
- Casulo, Carla
- Chen, James L.
- Clement, Jessica M
- Chism, David
- Curran, Catherine
- Daher, Ahmad
- Dahiya, Saurabh
- Deeken, John
- Elias, Rawad
- Faller, Bryan
- Fecher, Leslie A.
- Feldman, Lawrence E.
- Friese, Christopher R.
- Fu, Paul
- Fu, Julie
- Futreal, Andy
- Gainor, Justin
- Gill, David M.
- Gillaspie, Erin A.
- Giordano, Antonio
- Grothey, Axel
- Gulati, Shuchi
- Herbst, Roy
- Hershman, Dawn
- Hoskins, Kent
- Jain, Rohit K.
- Jabbour, Salma
- Jha, Alokkumar
- Johnson, Douglas B.
- Joshi, Monika
- Kelleher, Kaitlin
- Kharofa, Jordan
- Khan, Hina
- Koshkin, Vadim S.
- Kulkarni, Amit A.
- Lammers, Philip E.
- Lewis, Mark A.
- Li, Xuanyi
- Li, Ang
- LoRusso, Patricia
- Lustberg, Maryam B.
- Mahadevan, Daruka
- Markham, Merry Jennifer
- Matar, Sara
- McNair, Christopher
- McWeeney, Shannon
- Mehnert, Janice M.
- Menendez, Alvaro
- Messmer, Marcus
- Nagaraj, Gayathri
- Nagle, Sarah
- Naidoo, Jarushka
- Nakayama, John M.
- Narayan, Vikram
- Nelson, Heather H.
- Nemecek, Eneida R.
- Nguyen, Ryan
- Nuzzo, Pier Vitale
- Oberstein, Paul E.
- Olszewski, Adam J.
- Pasquinelli, Mary M.
- Philip, John
- Prabhakaran, Sabitha
- Puc, Matthew
- Revankar, Sanjay G.
- Rho, Young Soo
- Riely, Gregory J.
- Riess, Jonathan
- Rink, Cameron
- Robilotti, Elizabeth V.
- Rosenstein, Lori
- Routy, Bertrand
- Saif, M. Wasif
- Schapira, Lidia
- Serrano, Oscar
- Shah, Mansi
- Shah, Chintan
- Shergill, Ardaman
- Shouse, Geoffrey
- Soares, Heloisa P.
- Srivastava, Pramod K.
- Stover, Daniel G.
- Stratton, Jamie
- Stratton, Catherine
- Subbiah, Vivek
- Tamimi, Rulla
- Tannir, Nizar M.
- Venepalli, Neeta
- Verma, Amit K.
- Vikas, Praveen
- Wall, Sarah
- Weiss, Matthias
- Wise-Draper, Trisha
- Wood, William A.
- Xu, Wenxin (Vincent)
- Yackzan, Susan
- Zhang, Tian
- Zimmer, Andrea J.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 395
- Issue
- 10241
- Pages
- 1907-1918
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7255743
- OpenAlex
- W3030573714
- Cited by
- 1,726
- References
- 39
- Citations by year
- 2026: 30 · 2025: 59 · 2024: 112 · 2023: 234 · 2022: 360 · 2021: 595 · 2020: 332
- FWCI
- 137.30
- Type
- journal article
- Language
- en
- Update notices
- erratum (2020-09-12)
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- IRIS (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Cancer Society (P30CA016056, MRSG-16-152-01 -CCE)
- Vanderbilt University (TR000445, UL1‐TR000445)
- Vanderbilt Institute for Clinical and Translational Research (UL1 TR000445, UL1 TR000445 from NCATS/NIH)
- Hope Foundation
- National Institutes of Health (CA- 016672, UL1TR000445, CA023100, CA196521, TR000445, CA-060553, CA016056, CA-068485, CA013696, CA054174, UL1TR001863)
- National Human Genome Research Institute (T32HG008341)
- National Cancer Institute (CA068485, CA-054174, P30CA054174, CA 060553, U01CA231840, CA 016672, CA231840, UG1CA189974, CA023100, U10CA180888, CA189974, UG1CA189828, CA196521, CA016056., CA016672 to, CA013696, P50CA098131, P30CA023100, K12CA090625, T32CA009515, P30CA016672, P30CA068485, P30CA016056, P30CA060553, T32CA203703, P30CA013696, P30CA196521)
- National Center for Advancing Translational Sciences (TR-000445, CA054174)
- Topics
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- COVID-19 pandemic, SARS-CoV-2, cancer patients, 30-day mortality, prognostic factors, comorbidities, smoking, age, sex differences, breast cancer, prostate cancer, severe illness, mortality risk stratification, cancer survivorship
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Aged, Antiviral Agents, Cause of Death, Female, Humans, Hydroxychloroquine, Male, Middle Aged, Neoplasms, Pneumonia, Viral, Prognosis, Risk Factors, Comorbidity, Databases, Factual, Azithromycin, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review